Armenia Medical Device Registration: Dossier Amendments, Notification Procedure and Model Consolidation

1. Key takeaways

Decision No. 46, after its 2021 rewording, divides changes to the registration dossier into the general amendment procedure and the notification procedure, and retains the channel for consolidating multiple models into a single registration certificate. The conclusion of GRZAN: consolidation of multiple models requires 8 conditions, items a to h, to be met simultaneously, and the same manufacturer, the same technical documentation, the same risk class, and the same functional purpose and operating principle are the four hard gates; IVDs additionally require the same analyte. Consolidation planning must begin at the product development stage, because remedies after the fact are almost impossible.

2. Legal basis

3. Expert insights

Insight 1: the 2021 rewording wrote the notification procedure into the scope of application. Article 1 of the reworded Rules provides that the procedures established by the Rules include registration and assessment, the approval of expert opinions, the resolution of divergences in the approval of expert opinions, changes to the registration dossier, including processing by way of notification, the reissuance of registration certificates, the approval of expert opinions for already registered medical devices, and the suspension and revocation, meaning invalidation, of registration certificates. GRZAN points out that the phrase including processing by way of notification is a new expression introduced by the 2021 rewording: it means that low-risk changes no longer need to go through the full assessment procedure, which is a substantive benefit for the iterative maintenance of marketed products.

Insight 2: the eight consolidation conditions of Article 19, read one by one.

GRZAN comment: items a, b, c and h are the four conditions under which the attributes must be identical; items e, f and g are the three categories in which differences are allowed, covering configurations, technical parameters and dimension series, and in every case the differences must not affect the operating principle and the functional purpose.

Insight 3: dimension series and execution variants require group drawings. Item g of Article 19 further provides that, for a set of execution variants of a device, group drawings and/or group specifications must be completed. GRZAN points out that this is the attachment most often overlooked in consolidation applications; missing group drawings lead to the application being returned for completion, delaying the certificate update cycle.

Insight 4: the confidentiality scope of Article 18 sets the boundary of change communication. The provision states that, apart from the documents for use or operation of the medical device, the maintenance manual, labeling and packaging data, including full-color packaging and label artwork, and the label texts in Russian and in the national languages of the member states, the documents contained in the registration dossier are confidential information and are provided only to the interested authorized bodies, meaning expert organizations, of the member states. GRZAN points out that in change communication the instructions for use and the label texts are the contents that are necessarily reviewed in the open, and their versions must be kept current and consistent.

Insight 5: the two repealed decisions can no longer serve as the basis for consolidation. Board Decisions No. 116 of 2018-07-24, on distinguishing the component elements of medical devices, and No. 123, on the criteria for consolidating multiple models into a single registration certificate, were declared invalid by Board Decision No. 65 of 2023-05-23. GRZAN points out that any internal operating procedure still citing these two decisions should be updated immediately to Article 19 of Decision No. 46, so that consolidation arguments are founded on a valid legal basis.

4. Practical recommendations

1. Front-load consolidation planning into development: design the model family against the eight conditions at the product line planning stage, so that post-hoc remedies never become necessary.
2. Test the four must-be-identical conditions first: verify the manufacturer, technical documentation, risk class, and functional purpose and operating principle model by model; any mismatch means separate certificates.
3. Issue IVD certificates by analyte: file kits for different analytes separately and do not attempt consolidation across analytes.
4. Prepare group drawings and group specifications: for consolidations based on dimension series or execution variants, prepare the group drawings and group specifications together with the application.
5. Build a change classification table: sort common change items into the notification procedure or the general amendment procedure, reducing unnecessary full assessments.
6. Retire the repealed bases: update all internal standard entries that cite Decisions No. 116 and No. 123.

5. Verification checklist

1. □ The feasibility of consolidation has been verified model by model against the eight conditions a to h of Article 19.
2. □ It has been confirmed that all models within a single certificate are produced by the same manufacturer according to the same technical documentation.
3. □ It has been confirmed that all models share the same risk class and the same functional purpose and operating principle.
4. □ For IVD products, it has been confirmed that all models target the same analyte.
5. □ Group drawings and group specifications for dimension series or execution variants have been prepared.
6. □ A change classification table distinguishing the notification procedure from the general amendment procedure has been established.
7. □ Internal standard entries citing Decisions No. 116 and No. 123 have been retired.

Regulatory information verified as of October 30, 2026.

GRZAN service note. GRZAN supports manufacturers with change management and model consolidation for Eurasian Economic Union and Armenia registrations, including eight-condition consolidation audits, notification procedure mapping, group drawing preparation and retired-basis cleanup. Regulatory monitoring is updated continuously and confirmed against the official sources cited above. For inquiries, contact info@grzanglobal.com.